List your company

Hepatocellular Carcinoma Detection on Hepatocellular carcinoma (HCC)

100SensitivitynnU-Net
-4235077Jul 3, 2026

Evaluation results

MethodLinks
nnU-Net2026.07100—
Hep Par 1Reference Study=[5]2026.0796—
pCEAReference Study=[5], Positive Staining Pattern Definition=canalicular2026.0796—
Hep Par 1Reference Study=[4]2026.0795—
CK34Reference Study=[13], Positive Staining Pattern Definition=complete or diffuse staining pattern of sinusoidal endothelial cells (CD34)2026.0795—
CK34Reference Study=[21], Positive Staining Pattern Definition=complete or diffuse staining pattern of sinusoidal endothelial cells (CD34)2026.0794—
Hep Par 1Reference Study=[3]2026.0792—
Hep Par 1Reference Study=[2]2026.0790—
GPC3Reference Study=[13]2026.0788—
Hep Par 1Reference Study=[1]2026.0786—
GPC3Reference Study=[12]2026.0784—
GPC3Reference Study=[11]2026.0783—
GPC3Reference Study=[10]2026.0779—
GPC3Reference Study=[9]2026.0777—
GPC3Reference Study=[8]2026.0776—
GPC3Reference Study=[7]2026.0775—
pCEAReference Study=[18], Positive Staining Pattern Definition=canalicular2026.0771—
CK8/18Reference Study=[17]2026.0770—
pCEAReference Study=[2], Positive Staining Pattern Definition=canalicular2026.0769—
pCEAReference Study=[17], Positive Staining Pattern Definition=canalicular2026.0750—
CK7Reference Study=[2]2026.0721—
CK7Reference Study=[17]2026.0720—
MOC 31Reference Study=[1]2026.0714—
MOC 31Reference Study=[2]2026.0712—
CK19Reference Study=[2]2026.0710—
MOC 31Reference Study=[5]2026.077—
CK7Reference Study=[20]2026.077—
CK20Reference Study=[2]2026.075—
MOC 31Reference Study=[19]2026.070—
CK19Reference Study=[20]2026.070—
CK20Reference Study=[20]2026.070—